These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 36352211)

  • 1. Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.
    Veiga RN; Zambalde ÉP; Cox L; Jucoski TS; Kohler AF; Carvalho TM; Rodrigues AC; Ludwig B; Crowley K; de Oliveira JC; Cortez MA
    Adv Exp Med Biol; 2022; 1385():75-108. PubMed ID: 36352211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miRNAs in immune responses and immunotherapy in cancer.
    Cortez MA; Anfossi S; Ramapriyan R; Menon H; Atalar SC; Aliru M; Welsh J; Calin GA
    Genes Chromosomes Cancer; 2019 Apr; 58(4):244-253. PubMed ID: 30578699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the Diagnosis and Treatment of Cancer.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Immunol Invest; 2017 Nov; 46(8):880-897. PubMed ID: 29058545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer.
    Kousar K; Ahmad T; Abduh MS; Kanwal B; Shah SS; Naseer F; Anjum S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting microRNAs as key modulators of tumor immune response.
    Paladini L; Fabris L; Bottai G; Raschioni C; Calin GA; Santarpia L
    J Exp Clin Cancer Res; 2016 Jun; 35():103. PubMed ID: 27349385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment.
    Yang N; Zhu S; Lv X; Qiao Y; Liu YJ; Chen J
    Front Immunol; 2018; 9():2491. PubMed ID: 30443251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs Reprogram Tumor Immune Response.
    Cao W; Cheng W; Wu W
    Methods Mol Biol; 2018; 1699():67-74. PubMed ID: 29086368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications.
    Mondal P; Kaur B; Natesh J; Meeran SM
    Semin Cell Dev Biol; 2022 Apr; 124():99-113. PubMed ID: 33865701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer.
    Kipkeeva F; Muzaffarova T; Korotaeva A; Mansorunov D; Apanovich P; Nikulin M; Malikhova O; Stilidi I; Karpukhin A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs as novel immunotherapeutic tools against cancer.
    Kaur M; Kaur B; Konar M; Sharma S
    Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
    Smolle MA; Calin HN; Pichler M; Calin GA
    FEBS J; 2017 Jul; 284(13):1952-1966. PubMed ID: 28132417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.
    Mofed D; Omran JI; Sabet S; Baiomy AA; Emara M; Salem TZ
    Mol Biol Rep; 2022 Dec; 49(12):11775-11793. PubMed ID: 36207500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options.
    Meng Q; Deng Y; Lu Y; Wu C; Tang S
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):423-439. PubMed ID: 36378341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.
    Dong L; Tian X; Zhao Y; Tu H; Wong A; Yang Y
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
    Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy.
    Gilles ME; Slack FJ
    Expert Opin Ther Targets; 2018 Nov; 22(11):929-939. PubMed ID: 30328720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.